{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:06:41Z","timestamp":1769742401036,"version":"3.49.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.vaccine.2008.08.021","type":"journal-article","created":{"date-parts":[[2008,8,31]],"date-time":"2008-08-31T08:56:23Z","timestamp":1220172983000},"page":"5700-5711","source":"Crossref","is-referenced-by-count":46,"title":["Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1kDa offers long-lasting protection against experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"26","author":[{"given":"Shraddha","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Samant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pragya","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Khare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brijesh","family":"Sisodia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajit K.","family":"Shasany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2008.08.021_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2008.08.021_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.08.021_bib3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.185.5.867","article-title":"Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model","volume":"185","author":"Murray","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.08.021_bib4","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1016\/j.vaccine.2007.05.042","article-title":"Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response","volume":"25","author":"Bhowmick","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.08.021_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0952-7915(93)90033-O","article-title":"T-cell and cytokine responses in leishmaniasis","volume":"5","author":"Reed","year":"1993","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.08.021_bib6","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.161.11.6171","article-title":"LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile","volume":"161","author":"Skeiky","year":"1998","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.08.021_bib7","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis","volume":"70","author":"Coler","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.021_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00193391","article-title":"Immunobiology of experimental leishmaniasis","volume":"181","author":"Muller","year":"1992","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.08.021_bib9","first-page":"72","article-title":"Development of vaccines against leishmaniasis","volume":"76","author":"Modabber","year":"1990","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.vaccine.2008.08.021_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by the elicitation of CD4+T cells","author":"Coler","year":"2007","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.021_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0035-9203(03)90171-4","article-title":"Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guerrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers","volume":"97","author":"Kamil","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.021_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2249.2005.02768.x","article-title":"Dichotomy of protective cellular immune responses to human visceral leishmaniasis","volume":"140","author":"Khalil","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"21","key":"10.1016\/j.vaccine.2008.08.021_bib13","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2007.02.083","article-title":"Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial","volume":"25","author":"Lemesre","year":"2007","journal-title":"Vaccine"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2008.08.021_bib14","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante, RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2008.08.021_bib15","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.08.021_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0264-410X(02)00444-9","article-title":"Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis","volume":"21","author":"Santos","year":"2002","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2008.08.021_bib17","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"issue":"20\u201321","key":"10.1016\/j.vaccine.2008.08.021_bib18","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/S0264-410X(99)00058-4","article-title":"Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani","volume":"17","author":"Santos","year":"1999","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.021_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S0037-86821996000200008","article-title":"The FML (Fucose Mannose Ligand) of Leishmania donovani. A new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar","volume":"29","author":"Palatnik de Sousa","year":"1996","journal-title":"Rev Soc Bras Med Trop"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2008.08.021_bib20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN)","volume":"19","author":"da Silva","year":"2000","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2008.08.021_bib21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major","volume":"186","author":"Gurunathan","year":"1997","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2008.08.021_bib22","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.4049\/jimmunol.147.10.3538","article-title":"The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex","volume":"147","author":"Jardim","year":"1991","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.021_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.144.2.699","article-title":"Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis","volume":"144","author":"Jaffe","year":"1990","journal-title":"J Immunol"},{"issue":"8530","key":"10.1016\/j.vaccine.2008.08.021_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(87)90116-4","article-title":"Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis","volume":"1","author":"Convit","year":"1987","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2008.08.021_bib25","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.4049\/jimmunol.150.10.4713","article-title":"Mapping human T cell epitopes in Leishmania gp63: identification of cross-reactive and species-specific epitopes","volume":"150","author":"Russo","year":"1993","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.021_bib26","first-page":"439","article-title":"Animal models for vaccine studies for visceral leishmaniasis","volume":"123","author":"Garg","year":"2006","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.021_bib27","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"Khamesipour","year":"2006","journal-title":"Indian J Med Res"},{"issue":"15","key":"10.1016\/j.vaccine.2008.08.021_bib28","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2005.12.053","article-title":"Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis","volume":"24","author":"Garg","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2008.08.021_bib29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.vaccine.2004.06.054","article-title":"Isolation of integral membrane proteins of Leishmania promastigotes and evaluation of their prophylactic potential in hamsters against experimental visceral leishmaniasis","volume":"23","author":"Garg","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2008.08.021_bib30","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","volume":"174","author":"Basu","year":"2005","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.08.021_bib31","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36 (LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.021_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/prca.200780017","article-title":"Proteomic approaches for discovery of new targets for vaccine and therapeutics against visceral leishmaniasis","volume":"3","author":"Kumari","year":"2008","journal-title":"Proteomics\u2014Clinical Application"},{"issue":"5","key":"10.1016\/j.vaccine.2008.08.021_bib33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pmic.200600725","article-title":"Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes","volume":"7","author":"Gupta","year":"2007","journal-title":"Proteomics"},{"issue":"4","key":"10.1016\/j.vaccine.2008.08.021_bib34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00436-005-1339-1","article-title":"Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models","volume":"96","author":"Dube","year":"2005","journal-title":"Parasitol Res"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.021_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.021_bib36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2249.1997.4531351.x","article-title":"Fractionation of mycobacterial integral membrane proteins by continuous elution SDS-PAGE reveals the immunodominance of low molecular weight subunits for human T cells","volume":"109","author":"Mehrotra","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"5259","key":"10.1016\/j.vaccine.2008.08.021_bib37","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.021_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0003-2697(81)90179-2","article-title":"Silver staining of proteins in polyacrylamide gels","volume":"118","author":"Wray","year":"1981","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2008.08.021_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0003-2697(84)90782-6","article-title":"A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids","volume":"138","author":"Wessel","year":"1984","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2008.08.021_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0003-2697(92)90502-X","article-title":"Colorimetric quantitation of trace amounts of sodium lauryl sulfate in the presence of nucleic acids and proteins","volume":"207","author":"Arand","year":"1992","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2008.08.021_bib41","series-title":"The enzyme linked immunosorbent assay (ELISA): a guide with abstracts of microplate application","author":"Voller","year":"1979"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.021_bib42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2005.02745.x","article-title":"Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani","volume":"140","author":"Garg","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.08.021_bib43","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production","volume":"141","author":"Ding","year":"1988","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.021_bib44","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response","volume":"166","author":"Melby","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.08.021_bib45","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac950914h","article-title":"Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels","volume":"68","author":"Shevchenko","year":"1996","journal-title":"Anal Chem"},{"key":"10.1016\/j.vaccine.2008.08.021_bib46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","article-title":"Nitric oxide and macrophage function","volume":"15","author":"MacMicking","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2008.08.021_bib47","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1128\/IAI.65.9.3644-3647.1997","article-title":"Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages","volume":"65","author":"Nozaki","year":"1997","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2008.08.021_bib48","first-page":"468","article-title":"Safety and immunogenicity of an autoclaved Leishmania major vaccine","volume":"77","author":"Khalil","year":"2000","journal-title":"East Afr Med J"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2008.08.021_bib49","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/S0264-410X(01)00058-5","article-title":"Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG","volume":"19","author":"Misra","year":"2001","journal-title":"Vaccine"},{"issue":"1131","key":"10.1016\/j.vaccine.2008.08.021_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1098\/rstb.1984.0111","article-title":"Mechanisms of acquired immunity in leishmaniasis","volume":"307","author":"Howard","year":"1984","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.021_bib51","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.42.2.702-707.1983","article-title":"Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis","volume":"42","author":"Haldar","year":"1983","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.021_bib52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2307\/3284319","article-title":"Protection of mice against visceral leishmaniasis by immunization with promastigote antigen incorporated in liposomes","volume":"83","author":"Ali","year":"1997","journal-title":"J Parasitol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.08.021_bib53","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1128\/IAI.70.12.6697-6706.2002","article-title":"Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB\/c mice","volume":"70","author":"Afrin","year":"2002","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.021_bib54","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1365-2249.1999.00918.x","article-title":"Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis","volume":"116","author":"Kemp","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.021_bib55","first-page":"173","article-title":"Cytokine-producing T cell subsets in human leishmaniasis","volume":"48","author":"Kemp","year":"2000","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.021_bib56","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/IAI.61.3.1069-1073.1993","article-title":"Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis","volume":"61","author":"Kemp","year":"1993","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2008.08.021_bib57","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.152.12.5949","article-title":"Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis","volume":"152","author":"Carvalho","year":"1994","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.08.021_bib58","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/IAI.57.10.3091-3096.1989","article-title":"Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters","volume":"57","author":"Gifawesen","year":"1989","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.021_bib59","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/517817","article-title":"Splenic cytokine responses in Indian kala-azar before and after treatment","volume":"177","author":"Kenney","year":"1998","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.08.021_bib60","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.66.5.2135-2142.1998","article-title":"Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis","volume":"66","author":"Melby","year":"1998","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.021_bib61","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Interleukin 10 production correlates with pathology in human Leishmania donovani infections","volume":"92","author":"Ghalib","year":"1993","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.021_bib62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-3024.1992.tb00005.x","article-title":"Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens","volume":"14","author":"Rodrigues Junior","year":"1992","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2008.08.021_bib63","first-page":"153","article-title":"Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states","volume":"98","author":"Bretscher","year":"1997","journal-title":"Behring Inst Mitt"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2008.08.021_bib64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0031182097002175","article-title":"Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG","volume":"116","author":"Dube","year":"1998","journal-title":"Parasitology"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2008.08.021_bib65","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0264-410X(00)00398-4","article-title":"Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters","volume":"19","author":"Fragaki","year":"2001","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2008.08.021_bib66","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.vaccine.2008.03.003","article-title":"Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells","volume":"26","author":"Carrion","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2008.08.021_bib67","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2008.08.021_bib68","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant","volume":"20","author":"Skeiky","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.021_bib69","doi-asserted-by":"crossref","first-page":"F7","DOI":"10.1084\/jem.194.3.F7","article-title":"Leishmaniasis vaccination: targeting the source of infection","volume":"194","author":"Reed","year":"2001","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2008.08.021_bib70","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.021_bib71","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/IAI.70.2.851-858.2002","article-title":"Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans","volume":"70","author":"McCarthy","year":"2002","journal-title":"Infect Immun"},{"issue":"4855","key":"10.1016\/j.vaccine.2008.08.021_bib72","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.3285469","article-title":"Aldolase activity of a Plasmodium falciparum protein with protective properties","volume":"240","author":"Certa","year":"1988","journal-title":"Science"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2008.08.021_bib73","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1111\/j.1432-1033.2004.04450.x","article-title":"Cloning, over-expression, purification and characterization of Plasmodium falciparum enolase","volume":"271","author":"Pal-Bhowmick","year":"2004","journal-title":"Eur J Biochem"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.021_bib74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4049\/jimmunol.152.1.193","article-title":"T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase","volume":"152","author":"Reynolds","year":"1994","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.021_bib75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0166-6851(96)02748-X","article-title":"Cloning and characterisation of strain-specific transcripts encoding triosephosphate isomerase, a candidate vaccine antigen from Schistosoma japonicum","volume":"82","author":"Hooker","year":"1996","journal-title":"Mol Biochem Parasitol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.08.021_bib76","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/JCM.34.8.1918-1921.1996","article-title":"Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia","volume":"34","author":"Mitsutake","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.021_bib77","first-page":"81","article-title":"Effects of the disruption of the HSP70-II gene on the growth, morphology, and virulence of Leishmania infantum promastigotes","volume":"11","author":"Folgueira","year":"2008","journal-title":"Int Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.08.021_bib78","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4161\/cc.2.6.521","article-title":"HSP27 and HSP70: potentially oncogenic apoptosis inhibitors","volume":"2","author":"Garrido","year":"2003","journal-title":"Cell Cycle"},{"issue":"5230","key":"10.1016\/j.vaccine.2008.08.021_bib79","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1126\/science.7545313","article-title":"A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides","volume":"269","author":"Suto","year":"1995","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.021_bib80","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1128\/JCM.30.2.330-335.1992","article-title":"Recombinant Leishmania Hsp90 and Hsp70 are recognized by sera from visceral leishmaniasis patients but not Chagas\u2019 disease patients","volume":"30","author":"de Andrade","year":"1992","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.021_bib81","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/IAI.66.1.347-352.1998","article-title":"Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu\/nu BALB\/c mice","volume":"66","author":"Rico","year":"1998","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.021_bib82","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4049\/jimmunol.166.1.498","article-title":"Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning","volume":"166","author":"Probst","year":"2001","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.08.021_bib83","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0020-7519(02)00134-0","article-title":"Expression of calreticulin P-domain results in impairment of secretory pathway in Leishmania donovani and reduced parasite survival in macrophages","volume":"32","author":"Debrabant","year":"2002","journal-title":"Int J Parasitol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.08.021_bib84","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1128\/IAI.70.7.3576-3585.2002","article-title":"Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor","volume":"70","author":"Ben Achour","year":"2002","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2008.08.021_bib85","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1128\/IAI.69.8.4906-4915.2001","article-title":"Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response","volume":"69","author":"Kebaier","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.08.021_bib86","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1016\/j.vaccine.2008.06.102","article-title":"Induction of Th1-type cellular responses in cured\/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1kDa","volume":"26","author":"Kumari","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T20:19:07Z","timestamp":1684527547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08011146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":86,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0264410X08011146"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}